Market Research Report
Immune Health Supplements - Global Market Outlook (2018-2027)
|Published by||Stratistics Market Research Consulting||Product code||939157|
|Published||Content info||150 Pages
Delivery time: 2-3 business days
|Immune Health Supplements - Global Market Outlook (2018-2027)|
|Published: May 1, 2020||Content info: 150 Pages||
According to Stratistics MRC, the Global Immune Health Supplements Market is accounted for $15.41 billion in 2018 and is expected to reach $34.18 billion by 2027 growing at a CAGR of 9.26% during the forecast period. Rise in user consciousness regarding different health issues and increase in the population of baby boomers are the major factors driving the market growth. However, lack of awareness among consumers regarding these supplements is restraining the market growth.
Immune Health Supplements are used to strengthen the body's immune system. It consists of various nutrients and vitamins perform different functions in the body to boost up immune response towards pathogens.
Based on sales channel, the online retailing segment is likely to have a huge demand due to increase in usage of e-commerce websites among consumers across the world. By geography, North America is going to have a lucrative growth during the forecast period due to rising awareness regarding health and fitness and well-developed healthcare infrastructure.
Some of the key players profiled in the Immune Health Supplements Market include Bayer AG, NOW Foods, Cellderm Technologies Inc, Kerry Group, Alticor Inc. (Amway), Glanbia Plc, Koninklijke DSM N.V., USANA Health Sciences, Vital Nutrients, Nutramax Laboratories, EuroPharma Inc, Bio-Tech Pharmacal Inc, Danisco A/S, Seroyal International Inc and NutriGold Inc.
Sales Channels Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances